Hélène Puccio

Title: Hélène Puccio: Innovator in Neurological Research

Introduction

Hélène Puccio is a prominent inventor based in Illkirch, France. He has made significant contributions to the field of neurological research, particularly in the treatment of Friedreich's Ataxia. With a total of 2 patents, his work focuses on innovative methods to address neurological conditions.

Latest Patents

Puccio's latest patents include groundbreaking inventions aimed at treating Friedreich's Ataxia. The first patent, titled "Rescue of central and peripheral neurological phenotype of Friedreich's Ataxia by intravenous delivery," describes compositions and methods for treating this condition using adeno-associated virus (AAV) to deliver therapeutic agents. The second patent, "Methods and pharmaceutical composition for the treatment and the prevention of neurological phenotype associated with Friedreich Ataxia," relates to a vector that comprises a nucleic acid sequence encoding for the frataxin (FXN) gene. This invention is designed for the prevention and treatment of neurological phenotypes associated with Friedreich Ataxia in affected individuals.

Career Highlights

Throughout his career, Hélène Puccio has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His research has been pivotal in advancing the understanding and treatment of neurological disorders.

Collaborations

Puccio has collaborated with notable colleagues, including Dinah Wen-Yee Sah and Martin Goulet. These partnerships have further enriched his research and contributed to the development of innovative solutions in the field.

Conclusion

Hélène Puccio's contributions to neurological research, particularly through his patents, highlight his commitment to improving the lives of those affected by Friedreich's Ataxia. His work continues to inspire advancements in medical science and treatment methodologies.